Lenny Syriac George, NP-C | |
30 Prospect Ave, Hackensack, NJ 07601-1915 | |
(551) 996-4466 | |
Not Available |
Full Name | Lenny Syriac George |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 30 Prospect Ave, Hackensack, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063944973 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Lenny Syriac George, NP-C 30 Prospect Ave, Hackensack, NJ 07601-1915 Ph: (551) 996-4466 | Lenny Syriac George, NP-C 30 Prospect Ave, Hackensack, NJ 07601-1915 Ph: (551) 996-4466 |
News Archive
An estimated 70–80% of ventilated patients will experience ICU delirium, which causes patients to enter a confused state and can lead to long-term cognitive impairments and memory deficits. GlobalData, therefore, expects to see an increase in the administration of pharmacological treatments for ICU delirium as the COVID-19 outbreak continues.
The number of people who live with diabetes is on the rise. By estimates of the World Health Organization (WHO), one in eleven people are affected by the disease.
The Iowa Medicaid Enterprise (IME), a unique combination of State employees and commercial vendors responsible for managing Iowa's $3 billion Medicaid program, has chosen Ingenix to manage its Program Integrity initiative to help ensure that taxpayer dollars are properly spent.
As of April 13, 2010, Rhythmlink International has been granted its Health Canada Medical Device License and will now market and sell product in Canada. In accordance with the Medical Device Regulations, Section 36, of Health Canada's Therapeutic Products Directorate, Rhythmlink's Disposable Subdermal Needle Electrodes and EEG Electrodes both received individual licenses for their families of products.
MolecularHealth announced today the official launch of MolecularHealth COPE (Corporate Oncology Program for Employers), powered by its cancer treatment decision support offering, TreatmentMAP.
› Verified 8 days ago